0000950170-24-020397.txt : 20240226
0000950170-24-020397.hdr.sgml : 20240226
20240226181514
ACCESSION NUMBER: 0000950170-24-020397
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAUL STEVEN M
CENTRAL INDEX KEY: 0001237564
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 24680935
MAIL ADDRESS:
STREET 1: C/O ELI LITTY & CO
STREET 2: LIIY CORPORATE CENTER DC 1093
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 99 HIGH STREET
STREET 2: 26TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
ownership.xml
4
X0508
4
2024-02-23
false
0001771917
Karuna Therapeutics, Inc.
KRTX
0001237564
PAUL STEVEN M
C/O KARUNA THERAPEUTICS, INC.
99 HIGH STREET, 26TH FLOOR
BOSTON
MA
02110
true
false
false
false
false
Common Stock
2024-02-23
4
M
false
27510
7.27
A
38106
D
Common Stock
2024-02-23
4
M
false
4008
99.72
A
42114
D
Common Stock
2364
I
The Steven M. Paul Revocable Trust
Common Stock
83255
I
Spouse (Jann E. Paul GRAT III)
Common Stock
23230
I
Spouse (Jann E. Paul Revocable Trust)
Option (right to buy)
7.27
2024-02-23
4
M
false
27510
0
D
2028-08-08
Common Stock
27510
757045
D
Option (right to buy)
99.72
2024-02-23
4
M
false
4008
0
D
2030-02-13
Common Stock
4008
135992
D
This option vested as to 1/30th of the shares underlying the option award on each one month anniversary of the vesting commencement date of June 15, 2018, except that 274,594 shares vested upon the closing of our Series B financing in March 2019, and 98,069 shares vested upon the closing of our initial public offering.
This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of February 14, 2020, with additional vesting as to 6.25% of the shares underlying the option award on each three month anniversary thereafter.
/s/ Mia Kelley, Attorney-in-Fact
2024-02-26